Cargando...
Metastatic colorectal cancer: therapeutic options for treating refractory disease
Therapeutic options for chemorefractory metastatic colorectal cancer (mcrc) have significantly expanded since 2009. The oral targeted therapies regorafenib and trifluridine/tipiracil have been established to be efficacious and safe in patients with mcrc who have progressed beyond 2 or more lines of...
Gardado en:
| Publicado en: | Curr Oncol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Multimed Inc.
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6878938/ https://ncbi.nlm.nih.gov/pubmed/31819707 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.26.5575 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|